newsfilter
← Latest News
GlobeNewswire·

Ocuphire Pharma to Present at Euretina and Retina Society Conferences in October

FARMINGTON HILLS, Mich., Oct. 06, 2023 (GLOBE NEWSWIRE) -- Ocuphire Pharma, Inc. (NASDAQ:OCUP), a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing small-molecule therapies